News

Technology Upgrade and Mass Production of Anti-tumor Pharmaceutical Intermediates

To meet market demand for highly effective, low-toxic anti-tumor drugs, the company invested in R&D to upgrade the technology of a specific anti-tumor pharmaceutical intermediate. By optimizing the reaction route and improving the production process, the company not only reduced production costs by 30% but also controlled the product impurity content to below 0.1%. The technological upgrade enabled large-scale mass production, supplying 20 tons of high-quality anti-tumor pharmaceutical intermediates to downstream pharmaceutical companies monthly, helping to increase the production capacity of multiple anti-tumor drugs.

Collaboration among 4,000+ Factories for Emergency Supply of Agrochemicals

A major agricultural province was hit by an unexpected pest and disease outbreak, leaving local pesticide manufacturers in urgent need of agrochemical raw materials to ensure spring farming season. Leveraging its strategic partnership network of over 4,000 factories, the company quickly coordinated emergency production at three upstream plants, securing 500 tons of agrochemical raw materials within 72 hours. This effectively alleviated local pesticide supply pressures and ensured the orderly progress of spring farming season.

Custom R&D Collaboration for Cardiovascular Pharmaceutical Intermediates

A well-known pharmaceutical company urgently needed high-purity cardiovascular pharmaceutical intermediates to advance the development of a new antihypertensive drug. Leveraging its in-house R&D team, the company conducted customized technical research tailored to the client's needs, completing process optimization and pilot production of the target intermediate within three months, achieving a purity of 99.8%. Subsequent large-scale production support helped the pharmaceutical company smoothly advance its new drug clinical trials. This led to the establishment of a long-term strategic partnership with an annual value exceeding 20 million yuan.